EMAT arrives at its August 20 earnings date carrying one of the most punishing year-to-date drawdowns in its peer group, with the borrow market signalling that short sellers remain firmly committed to the trade.
The lending setup is the standout story. Availability has tightened to roughly 21% — meaning only about one share remains available to borrow for every four already lent out. That is down 16% in a single week and not far above the 52-week floor of 0.18%, the tightest the pool has ever been. Borrowing costs reflect that pressure: the cost to borrow is running at 31%, up 19% over the past month and well above mid-July levels. Short interest has actually edged lower — down roughly 22% over the past week to around 346,000 shares — but the tightening availability tells a different story about demand pressure in the lending pool.
The price action frames the stakes plainly. EMAT fell nearly 8% on August 17 alone, even after a 10% weekly bounce. The stock is down 44% over the past month. The ORTEX short score has drifted slightly lower this week to 59.9 from 63 ten days ago, but remains elevated — consistent with a stock where bearish positioning is structural rather than opportunistic. Peers are moving differently: correlated names like AZS and BGL gained roughly 10% on the week, while TSK added nearly 7%. EMAT's continued underperformance is not a sector-wide story alone.
The fundamental picture offers little support for a bull case near-term. The ORTEX stock score is 31, down from 44 a month ago, with weakness concentrated in profitability metrics and price momentum. The company's enterprise value is estimated at roughly $23 million — a micro-cap footprint that amplifies the impact of any share-price move. Insider activity is not a useful signal here: the only recent trade on record is a director purchase of $14,000 worth of shares in January, now more than seven months stale. Institutional ownership is heavily concentrated, with two insiders holding around 77% of shares between them, which limits the float available to trade — and to borrow.
Historical reactions add a sharp asymmetry to consider. The May 2026 print produced a one-day move of nearly 19% to the upside, followed by a five-day reversal back to flat. The prior event in March delivered a 22% gain on the day and held those gains across the following week. But the February event fell 14% on the day and extended losses to -19% over five sessions. With availability tight, short interest still present, and the stock already in deep drawdown, Thursday's print is a test of whether any operational progress can interrupt what has been a sustained, broad-based repricing of the company's prospects.
See the live data behind this article on ORTEX.
Open EMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
